Zephyr AI is a healthcare technology company with a focus on precision medicine, particularly in areas like oncology and cardiometabolic diseases. Founded by Red Cell Partners in 2021, Zephyr AI leverages its extensive clinicogenomic data—including over 68 million patient records—and cutting-edge artificial intelligence algorithms to generate novel insights for drug discovery, patient care, and disease management. The company employs advanced machine learning techniques to analyze multi-dimensional healthcare data, making it possible to uncover patterns and biological insights that guide personalized treatment decisions, enhance clinical trials, and potentially repurpose existing drugs​.
Zephyr AI’s innovative approach lies in its combination of massive, diverse datasets with AI algorithms that interpret biological context. This enables the company to deliver unique, data-backed insights into patient selection and therapeutic effectiveness, which is particularly beneficial in precision medicine where understanding individual variability is crucial. In particular, its technology addresses the challenge of aligning real-world patient data with drug development and deployment, which has historically been a difficult task for healthcare AI​.
Key investors in Zephyr AI include Echo Investment Capital, Eli Lilly, EPIQ Capital Group, Revolution Growth, Lerner Group, and M-Cor Holdings, among others. These investors support the company’s vision to enhance patient outcomes through data-driven AI solutions and to redefine drug discovery processes​.
In terms of its AI category, Zephyr AI falls within healthtech and precision medicine, specifically focusing on the intersection of AI, big data, and healthcare. It uses AI not just for predictive modeling but also to create actionable insights in drug development, positioning it as a leader in AI-enabled healthcare research.
Zephyr AI is based in Fairfax Station, Virginia, USA. Specializing in the AI industry, Zephyr AI pioneers innovative solutions and advancements in artificial intelligence. Zephyr AI, funded over $100 million, is well-positioned to drive significant impact and growth in the AI sector. For more information, please visit zephyrai.bio.
To claim this startup page, go to the Contact page and send us a message with your full name, startup name, job title, and startup email address. We will review your request and get back to you. Once verified, you can update your startup information.